The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
The Serotonin Syndrome
Abstract
The serotonin syndrome is a potentially life-threatening drug reaction that may result from therapeutic medication use, self-poisoning, or interactions between drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“that is responsible for transient serotoninrelated symptoms such as nausea, anxiety, hypertension, tachycardia, visual deficits, motor incoordination, and mild tremors, even at therapeutic doses.”
From The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges (2024) · cites this paper as [42]
In the citing paper
“Both psychedelic effects and serotonin syndrome are associated with an increase in 5-HT2A neurotransmission 42,43”
From The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges (2024) · cites this paper as [42]
In the citing paper
“Serotonin stimulation is known to affect the whole organism not just the brain. It causes vegetative changes such as increase in systolic and diastolic blood pressure, pulse rate, provokes nausea, vomiting, and pupil dilation (Boyer and Shannon, 2005).”
From The therapeutic potentials of Ayahuasca: possible effects against various diseases of civilization (2016) · cites this paper as Boyer and Shannon, 2005
Citations
Cites
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).
Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R., Mylecharane, E. J., Saxena, P. R., & Humphrey, P. P. A. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06783-3 · Cited by 3,025
Sternbach, H. A. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.6.705 · Cited by 1,349
Dunkley, E. J. C., Isbister, G. K., Sibbritt, D. W., Dawson, A. H., & Whyte, I. M. (2003) · QJM · doi:10.1093/qjmed/hcg109 · Cited by 1,032
Neuroleptic malignant syndrome
Levenson, J. L. (1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.10.1137 · Cited by 984
Watson, W. A., Litovitz, T. L., Rodgers, G. C., Klein‐Schwartz, W., Youniss, J., Rose, S. R., Borys, D. J., & May, M. E. (2003) · The American Journal of Emergency Medicine · doi:10.1016/s0735-6757(03)00088-3 · Cited by 481
Interactions Between Herbal Medicines and Prescribed Drugs
Izzo, A., & Ernst, E. (2012) · Drugs · doi:10.2165/00003495-200161150-00002 · Cited by 464
Relative Toxicity of Selective Serotonin Reuptake Inhibitors (SSRIs) in Overdose
Isbister, G. K., Bowe, S. J., Dawson, A. H., & Whyte, I. M. (2004) · Journal of Toxicology Clinical Toxicology · doi:10.1081/clt-120037428 · Cited by 432
Asch, D. A., & Parker, R. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198803243181209 · Cited by 396
Laine, K., Heikkinen, T., Ekblad, U., & Kero, P. O. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.7.720 · Cited by 329
Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity
Parrott, A. C. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00711-0 · Cited by 325
Research works printed but not linked: 8
- Sampson E, 1999, Br J Gen Pract, 49, 867
- Mackay FJ, 1999, Br J Gen Pract, 49, 871
- Hoyer D, 1994, Pharmacol Rev, 46, 157
- Saper CB. Brain stem modulation of sensation, movement, and consciousness. In: Kandel ER, Schwartz JH, Jessell TM, eds. Principles of neural science. 4th ed. New York: McGraw-Hill, 2000:896.
- Kline SS, 1989, Clin Pharm, 8, 510
- Whyte I, 2002, J Toxicol Clin Toxicol, 40, 668
- Boddy R, 2004, J Toxicol Clin Toxicol, 42, 725
- Olsen D, 2004, J Toxicol Clin Toxicol, 42, 744
Cited by
Sorted by citations
Items 501–600 of 1,000
Tramadol overdose: review of the literature
Afshari, R., Afshar, R., & Mégarbane, B. (2011) · Réanimation · doi:10.1007/s13546-011-0306-3 · Cited by 21
Serotonin toxicity precipitated by concomitant use of citalopram and methylene blue
Khavandi, A., Whitaker, J., & Gonna, H. (2008) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2008.tb02168.x · Cited by 21
Using evolutionary tools to search for novel psychoactive plants
Halse-Gramkow, M., Ernst, M., Rønsted, N., Dunn, R. R., & Saslis‐Lagoudakis, C. H. (2016) · Plant Genetic Resources · doi:10.1017/s1479262116000344 · Cited by 20
Cardiovascular side effects of newer antidepressants.
Fernandez, A., Bang, S. E., Srivathsan, K., & Vieweg, W. V. R. (2007) · PubMed · Cited by 21
Fibromyalgia: Should the treatment paradigm be monotherapy or combination pharmacotherapy?
Mease, P. J., & Seymour, K. (2008) · Current Pain and Headache Reports · doi:10.1007/s11916-008-0068-4 · Cited by 21
Reported Cases of Serotonin Syndrome in MDMA Users in FAERS Database
Makunts, T., Jerome, L., Abagyan, R. A., & de Boer, A. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.824288 · Cited by 20
Choe, C. J., Emslie, G. J., & Mayes, T. L. (2012) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2012.07.002 · Cited by 22
Atiya, A., Majrashi, T. A., Akhtar, S., Khan, A. A., Asiri, A. M. S., Al-Zahrania, H. J., Alnami, R. S., Alsharif, S. A., Amer, T., Faiz, Z. A., et al. (2022) · Phytomedicine Plus · doi:10.1016/j.phyplu.2022.100315 · Cited by 20
Park, I., Choi, M., Kim, J., Jang, S., Kim, D., Kim, J., Choe, Y., Geum, D., Yu, S.-W., Choi, J., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06647-y · Cited by 20
Considerations in the Treatment of Geriatric Depression
Rojas‐Fernandez, C. H., Miller, L. J., & Sadowski, C. A. (2010) · Research in Gerontological Nursing · doi:10.3928/19404921-20100526-01 · Cited by 20
Gentili, F., Pizzinat, N., Ordener, C., Marchal-Victorion, S., Maurel, A., Hofmann, R., Renard, P., Delagrange, P., Pigini, M., Parini, A., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060605r · Cited by 20
Serotonin Syndrome Associated With Citalopram and Meperidine
Altman, E. M., & Manos, G. H. (2007) · Psychosomatics · doi:10.1176/appi.psy.48.4.361-a · Cited by 20
Medical Complications of Psychiatric Treatment
Smith, F. A., Wittmann, C. W., & Stern, T. A. (2008) · Critical Care Clinics · doi:10.1016/j.ccc.2008.05.004 · Cited by 20
The antimalarial drug quinine interferes with serotonin biosynthesis and action
Islahudin, F. H., Tindall, S. M., Mellor, I. R., Swift, K., Christensen, H. E. M., Fone, K. C. F., Pleass, R. J., Ting, K., & Avery, S. V. (2014) · Scientific Reports · doi:10.1038/srep03618 · Cited by 20
Neuroleptic Malignant Syndrome Versus Serotonin Syndrome: The Search for a Diagnostic Tool
Sokoro, A. A. H., Zivot, J., & Ariano, R. E. (2011) · Annals of Pharmacotherapy · doi:10.1345/aph.1p787 · Cited by 20
Hudd, T. R., Blake, C. S., Rimola-Dejesus, Y., Nguyen, T.-T., & Zaiken, K. (2019) · Journal of Pharmacy Practice · doi:10.1177/0897190019841742 · Cited by 20
Methylene blue inhibits function of the 5‐HT transporter
Öz, M., Isaev, D. S., Lorke, D. E., Hasan, M., Petroianu, G. A., & Shippenberg, T. S. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01462.x · Cited by 20
Jamuar, S. S., Newton, S. A., Prabhu, S. P., Hecht, L. E., Costas, K. C., Wessel, A. E., Harris, D. J., Anselm, I. A., & Berry, G. T. (2012) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2012.05.018 · Cited by 20
Hilli, J., Korhonen, T., & Laine, K. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.08.014 · Cited by 20
Dyskinesias associated with atomoxetine in combination with other psychoactive drugs
Bond, G. R., Garro, A. C., & Gilbert, D. L. (2007) · Clinical Toxicology · doi:10.1080/15563650600981178 · Cited by 20
The failure of anxiolytic therapies in early clinical trials: what needs to be done
Stewart, A., Nguyen, M., Poudel, M. K., Warnick, J. E., Echevarria, D. J., Beaton, E. A., Song, C., & Kalueff, A. V. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.1019063 · Cited by 24
Ghosh, R., & Liddle, B. J. (2010) · Postgraduate Medical Journal · doi:10.1136/pgmj.2010.104976 · Cited by 20
Zhang, B., Hao, Y., Jia, F., Li, X., Ren, Y., Zhou, P., Liu, W., & Wing, Y. K. (2013) · Sleep Medicine · doi:10.1016/j.sleep.2013.07.019 · Cited by 20
Dexmedetomidine in the Treatment of Serotonin Syndrome
Rushton, W. F., & Charlton, N. P. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028014549184 · Cited by 20
Silva, S. M., Martinho, A., Moreno, I., Silvestre, S., Breitenfeld, L., Alves, G., Duarte, A. P., Domingues, F., & Gallardo, E. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.11.004 · Cited by 20
Serotoninsyndrom und medikamentöse Schmerztherapie
Schenk, M., & Wirz, S. (2015) · Der Schmerz · doi:10.1007/s00482-015-1512-0 · Cited by 20
Ecstasy (MDMA) and its effects on kidneys and their treatment: a review.
Bora, F., Yılmaz, F., & Bora, T. (2016) · PubMed Central · doi:10.22038/ijbms.2016.7813 · Cited by 20
Serotonin syndrome in a patient taking Lexapro and Flexeril: a case report
Day, L. T., & Jeanmonod, R. (2008) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2008.03.028 · Cited by 20
Recognizing Serotonin Toxicity in the Pediatric Emergency Department
Kant, S., & Liebelt, E. L. (2012) · Pediatric Emergency Care · doi:10.1097/pec.0b013e31826289d9 · Cited by 19
Drugs of Abuse—Opioids, Sedatives, Hypnotics
Azevedo, K., Johnson, M., Wassermann, M., & Evans-Wall, J. (2021) · Critical Care Clinics · doi:10.1016/j.ccc.2021.03.003 · Cited by 19
Predicting serotonin toxicity in serotonin reuptake inhibitor overdose
Cooper, J. M., Duffull, S. B., & Isbister, G. K. (2022) · Clinical Toxicology · doi:10.1080/15563650.2022.2151455 · Cited by 19
The current state of ayahuasca research in animal models: A systematic review
Daldegan‐Bueno, D., Simionato, N. M., Favaro, V. M., & Maia, L. O. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110738 · Cited by 21
Kulkarni, R. R., & Kulkarni, P. R. (2013) · Indian Journal of Psychological Medicine · doi:10.4103/0253-7176.122245 · Cited by 19
Williams, S. K., Lauder, J. M., & Johns, J. M. (2011) · Current Neuropharmacology · doi:10.2174/157015911796557957 · Cited by 18
Serotonin syndrome associated with polypharmacy in the elderly
Poeschla, B., Bartle, P., & Hansen, K. P. (2011) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2010.11.015 · Cited by 19
Genetics of Depression: An Overview of the Current Science
Elder, B. L., & Mosack, V. (2011) · Issues in Mental Health Nursing · doi:10.3109/01612840.2010.541588 · Cited by 24
Pharmacotherapeutic options for the treatment of depression in patients with chronic kidney disease.
Raymond, C. B., Wazny, L. D., & Honcharik, P. L. (2008) · PubMed · Cited by 19
Dietary tryptophan supplementation and affective state in pigs
Stracke, J., Otten, W., Tuchscherer, A., Witthahn, M., Metges, C. C., Puppe, B., & Düpjan, S. (2017) · Journal of Veterinary Behavior · doi:10.1016/j.jveb.2017.03.009 · Cited by 18
Culbertson, V. L., Rahman, S. E., Bosen, G. C., Caylor, M. L., Echevarria, M. M., & Xu, D. Q. (2018) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2163 · Cited by 20
Chronic serotonin syndrome: A retrospective study
Prakash, S., Rathore, C., Rana, K., Roychowdhury, D., & Lodha, D. (2021) · World Journal of Psychiatry · doi:10.5498/wjp.v11.i4.124 · Cited by 19
Lee‐Kelland, R., Zehra, S., & Mappa, P. (2018) · BMJ Case Reports · doi:10.1136/bcr-2018-225529 · Cited by 19
Behavioral effects of dipropyltryptamine in rats: evidence for 5-HT1A and 5-HT2A agonist activity
Li, J., Rice, K. C., & France, C. P. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3281f19ca0 · Cited by 19
Serotonin syndrome and rhabdomyolysis in venlafaxine poisoning: a case report.
Hanekamp, B., Zijlstra, J. G., Tulleken, J. E., Ligtenberg, J. J. M., Werf, V. D. T., & Hofstra, L. S. (2005) · PubMed · Cited by 19
Köster, M., Grohmann, R., Engel, R. R., Nitsche, M. A., Rüther, E., & Degner, D. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3281-8 · Cited by 18
Glannon, W. (2018) · doi:10.1093/med/9780198758853.001.0001 · Cited by 29
The effect of fluoxetine on penicillin-induced epileptiform activity
Aygün, H. (2019) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2019.03.050 · Cited by 18
Schäfer, W., Reinders, T., Riedel, O., & Haug, U. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14564 · Cited by 18
Kufel, W. D., Parsels, K. A., Blaine, B. E., Steele, J. M., Seabury, R. W., & Asiago‐Reddy, E. (2023) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2023.106843 · Cited by 18
Serotonin syndrome: An often-neglected medical emergency
Badar, A. (2024) · Journal of Family and Community Medicine · doi:10.4103/jfcm.jfcm_236_23 · Cited by 20
Inpatient Management of Hyperemesis Gravidarum
Clark, S. M., Zhang, X., & Goncharov, D. A. (2024) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000005518 · Cited by 19
Tao, W., Zhang, Y., Wang, B., Nie, S., Li, F., Xiao, J., & Wu, Y. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.03.023 · Cited by 21
Recognition and management of perioperative serotonin syndrome
Wilson, L., Rooney, T., Baugh, R. F., & Millington, B. (2011) · American Journal of Otolaryngology · doi:10.1016/j.amjoto.2011.10.002 · Cited by 18
Fidani, C., Freund, F., & Grant, R. (2014) · Animals · doi:10.3390/ani4020292 · Cited by 18
A comparison of midazolam and dexmedetomidine for the recovery of serotonin syndrome in rats
Kawano, T., Takahashi, T., Kaminaga, S., Kadono, T., Yamanaka, D., Iwata, H., Eguchi, S., & Yokoyama, M. (2015) · Journal of Anesthesia · doi:10.1007/s00540-014-1973-9 · Cited by 18
Bazzan, A. J., Zabrecky, G. P., Monti, D., & Newberg, A. B. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.892420 · Cited by 18
Toxidrome-based Approach to Common Poisonings
Mégarbane, B. (2014) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.22038/apjmt.2014.2463 · Cited by 18
Headache as a presenting feature in patients with serotonin syndrome: A case series
Prakash, S., Belani, P., & Trivedi, A. M. (2013) · Cephalalgia · doi:10.1177/0333102413495968 · Cited by 18
Serotonin Syndrome in Tapentadol Literature: Systematic Review of Original Research
Gressler, L. E., Hammond, D. A., & Painter, J. T. (2017) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/15360288.2017.1416440 · Cited by 18
Commonly Initiated Opioids and Risk of Fracture Hospitalizations in United States Nursing Homes
Hunnicutt, J. N., Hume, A. L., Liu, S., Ulbricht, C. M., Tjia, J., & Lapane, K. L. (2018) · Drugs & Aging · doi:10.1007/s40266-018-0583-x · Cited by 18
Serotonin syndrome from sertraline monotherapy
Duignan, K. M., Quinn, A. M., & Matson, A. M. (2019) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2019.158487 · Cited by 18
Sailem, H., & Zen, A. A. H. (2020) · Scientific Reports · doi:10.1038/s41598-020-70440-0 · Cited by 22
Fatal serotonin toxicity caused by moclobemide and fluoxetine overdose.
Wu, M.-L., & Deng, J. (2011) · PubMed · Cited by 18
Commonly used gastrointestinal drugs.
Aggarwal, A., & Bhatt, M. (2014) · Handbook of Clinical Neurology · doi:10.1016/b978-0-7020-4087-0.00043-7 · Cited by 17
Diphenhydramine overdose mimicking serotonin syndrome
Tanaka, T., Takasu, A., Yoshino, A., Terazumi, K., Ide, M., Nomura, S., & Sakamoto, T. (2011) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2011.02234.x · Cited by 18
The role of toxicology interpretations in prevention of sudden death
Schumann, J., Gerostamoulos, D., & Drummer, O. H. (2012) · Forensic Science Medicine and Pathology · doi:10.1007/s12024-011-9309-7 · Cited by 18
Exacerbation of Myoclonus by Memantine in a Patient With Alzheimer Disease
Papageorgiou, S. G., Kontaxis, T., Antelli, A., & Kalfakis, N. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000264995.31771.05 · Cited by 18
Yuen, E. Y., Qin, L., Wei, J., Liu, W., Liu, A., & Yan, Z. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.567610 · Cited by 18
Cheng, Y., Liang, C.-M., & Liu, H. (2015) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000076 · Cited by 18
Krishnamoorthy, S., Ma, Z., Zhang, G., Wei, J., Auerbach, S. B., & Tao, R. (2010) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2010.00586.x · Cited by 18
Brain pathology in fatal serotonin syndrome: Presentation of two cases
Slettedal, J. K., Nilssen, D. O. V., Magelssen, M., Løberg, E. M., & Mæhlen, J. (2010) · Neuropathology · doi:10.1111/j.1440-1789.2010.01153.x · Cited by 18
Serotonin Syndrome after Sertraline Overdose in a Child: A Case Report
Grenha, J., Garrido, A., Brito, H., Oliveira, M. J., & Santos, F. (2013) · Case Reports in Pediatrics · doi:10.1155/2013/897902 · Cited by 18
Rollema, H., Wilson, G. G., Lee, T. C., Folgering, J. H. A., & Flik, G. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.10.015 · Cited by 17
Cohen, N. A., Choi, D., Garcia, N. M., Choi, N. K., Picker, E. A., Cleveland, N. K., Cohen, R. D., Dalal, S. R., Pekow, J. R., & Rubin, D. T. (2023) · Digestive Diseases and Sciences · doi:10.1007/s10620-023-08178-8 · Cited by 19
Pannu, A. S., & Goyal, R. K. (2024) · Current Drug Safety · doi:10.2174/0115748863301630240417071353 · Cited by 21
Rare Case of Serotonin Syndrome With Therapeutic Doses of Paroxetine
Paruchuri, P., Godkar, D., Anandacoomarswamy, D., Sheth, K. N., & NIRANJAN, S. (2006) · American Journal of Therapeutics · doi:10.1097/01.mjt.0000245221.36160.5c · Cited by 17
Marchocki, Z., Russell, N. E., & O’Donoghue, K. (2013) · Obstetric Medicine · doi:10.1177/1753495x13495194 · Cited by 17
Baik, S. H., Choi, Y. K., Kim, H. S., Yoon, Y. K., Sohn, J. W., & Kim, M. J. (2015) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp150208 · Cited by 17
Zaitsu, K., Noda, S., Iguchi, A., Hayashi, Y., Ohara, T., Kimura, Y., Koketsu, Y., Kosaki, T., Kusano, M., Sato, T., et al. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.06.031 · Cited by 17
Fatal overdose with a combination of SNRIs venlafaxine and duloxetine
Alibegović, A., Kariž, S., & Volavšek, M. (2019) · Forensic Science Medicine and Pathology · doi:10.1007/s12024-019-00097-3 · Cited by 17
Serotonin Syndrome in a Patient with Chronic Pain Polypharmacy: Table 1
Lamberg, J. J., & Gordin, V. (2012) · Pain Medicine · doi:10.1111/j.1526-4637.2012.01468.x · Cited by 17
Barry, J. D., & Wills, B. K. (2011) · Neurologic Clinics · doi:10.1016/j.ncl.2011.05.006 · Cited by 17
Safety Profile of Treatment in Diabetic Peripheral Neuropathic Pain: Table 1
Robinson‐Papp, J., & Simpson, D. M. (2007) · Pain Medicine · doi:10.1111/j.1526-4637.2007.00351.x · Cited by 17
“Robo-Tripping”: Dextromethorphan Abuse and its Anesthetic Implications
Linn, K. A., Long, M. T., & Pagel, P. S. (2014) · Anesthesiology and Pain Medicine · doi:10.5812/aapm.20990 · Cited by 17
Kreislaufstillstand unter besonderen Umständen
Soar, J., Deakin, C. D., Nolan, J. P., Abbas, G., Alfonzo, A. V. M., Handley, A. J., Lockey, D., Perkins, G. D., Thies, K., Böttiger, B. W., et al. (2006) · Notfall + Rettungsmedizin · doi:10.1007/s10049-006-0798-y · Cited by 17
The Gut-Brain Axis in Alzheimer’s Disease: Exploring Microbial Influences and Therapeutic Strategies
Mustafa, M. A., Vadia, N., Varma, P., Al‐Shaker, H., Mohanty, B., Dhyani, A., Kaur, I., Chauhan, A. S., & Garg, G. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05474-4 · Cited by 18
Effects of fentanyl on serotonin syndrome-like behaviors in rats
Kitamura, S., Kawano, T., Kaminaga, S., Yamanaka, D., Tateiwa, H., Locatelli, F. M., & Yokoyama, M. (2015) · Journal of Anesthesia · doi:10.1007/s00540-015-2092-y · Cited by 16
Serotonin Syndrome Associated with Metaxalone Overdose
Bosak, A. R., & Skolnik, A. B. (2014) · Journal of Medical Toxicology · doi:10.1007/s13181-014-0404-5 · Cited by 16
Okafor, H. U., Shu, E. N., & Oguonu, T. A. (2010) · Journal of Tropical Pediatrics · doi:10.1093/tropej/fmq004 · Cited by 16
Elucidating the Mechanism of Action and Potential Interactions of MAO-B Inhibitors
Bainbridge, J. L., Page, R. L., II, & Ruscin, J. M. (2008) · Neurologic Clinics · doi:10.1016/j.ncl.2008.05.002 · Cited by 16
The psychoactive drug 25B-NBOMe recapitulates rhabdomyolysis in zebrafish larvae
Kawahara, G., Maeda, H., Kikura‐Hanajiri, R., Yoshida, K.-I., & Hayashi, Y. K. (2017) · Forensic Toxicology · doi:10.1007/s11419-017-0366-9 · Cited by 16
Visco, D. B., Manhães‐de‐Castro, R., Chaves, W. F., Lacerda, D. C., Pereira, S. D. C., Ferraz‐Pereira, K. N., & Toscano, A. E. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.09.004 · Cited by 16
Alberghina, D., Tropia, E., Piccione, G. G., Giannetto, C., & Panzera, M. (2019) · Journal of Veterinary Behavior · doi:10.1016/j.jveb.2019.04.005 · Cited by 16
Deryabina, I., Andrianov, V. V., Николаевна, М. Л., Bogodvid, T. K., & Латыпович, Г. Х. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062087 · Cited by 16
Howard, P. D., Twycross, R., Shuster, J. L., Mihalyo, M., & Wilcock, A. (2012) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2012.09.001 · Cited by 21
Cardiogenic shock due to takotsubo cardiomyopathy associated with serotonin syndrome
Sasaki, H., Yumoto, K., Nanao, T., Nishizawa, H., Funada, S., Aoki, H., & Kato, K. (2012) · Journal of Cardiology Cases · doi:10.1016/j.jccase.2012.07.011 · Cited by 16
Fièvre médicamenteuse : un diagnostic à ne pas oublier
Vodovar, D., Beller, C. L., Louët, A. L., Hanslik, T., & Mégarbane, B. (2013) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2013.02.023 · Cited by 16
Obtundation and seizure following ondansetron overdose in an infant
George, M., Al-Duaij, N., O’Donnell, K. A., & Shannon, M. W. (2008) · Clinical Toxicology · doi:10.1080/15563650802304401 · Cited by 16
Self-citationSerotonin Syndrome Probably Triggered by a Morphine–Phenelzine Interaction
Mateo‐Carrasco, H., Aguilera, E. M., García‐Torrecillas, J. M., & Al‐Robb, H. A. (2015) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1581 · Cited by 16
Duloxetine Augmentation in Resistant Obsessive-Compulsive Disorder
Mowla, A., Boostani, S., & Dastgheib, S. A. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000592 · Cited by 16
Patel, Y. A., & Marzella, N. (2017) · American Journal of Case Reports · doi:10.12659/ajcr.904375 · Cited by 16
Metadata
- Authors
- Boyer, E. W., & Shannon, M.
- Affiliations
- Boston Children's Hospital (US)
- ORCID
- Boyer, Edward W.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-03-17
- Volume
- 352
- Issue
- 11
- Pages
- 1112-1120
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2123778879
- Cited by
- 1,821
- References
- 49
- Citations by year
- 2026: 47 · 2025: 65 · 2024: 84 · 2023: 53 · 2022: 78 · 2021: 74 · 2020: 92 · 2019: 86 · 2018: 99 · 2017: 96 · 2016: 98 · 2015: 112 · 2014: 121 · 2013: 109 · 2012: 93
- FWCI
- 11.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (DA14929, R21DA014929)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- serotonin syndrome, adverse drug reactions, drug interactions, self-poisoning, serotonin receptor agonists
- MeSH terms
- Algorithms, Antidepressive Agents, Diagnostic Errors, Drug Interactions, Humans, Monoamine Oxidase Inhibitors, Selective Serotonin Reuptake Inhibitors, Serotonin Syndrome, Drug Overdose
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review